We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Nebivolol Ameliorates Cisplatin-Induced Nephrotoxicity in Rats.
- Authors
Morsy, Mohamed A.; Heeba, Gehan H.
- Abstract
Treatment with cisplatin is associated with dose-limiting side effects, mainly nephrotoxicity. On the other hand, nebivolol, a β1-adrenoceptor antagonist, exhibits vasodilatory and antioxidative properties. This study aimed to determine whether nebivolol possesses a protective effect against cisplatin nephrotoxicity and explore many mechanisms underlying this potential effect. Nephrotoxicity was induced in Wistar rats by a single intraperitoneal injection of cisplatin (6 mg/kg) on day 2. Nebivolol (10 mg/kg) was administered orally for 7 consecutive days. Nebivolol showed a nephroprotective effect as demonstrated by the significant reduction in the elevated levels of serum creatinine and urea as well as renal levels of malondialdehyde, nitric oxide products (nitrite/nitrate), inducible nitric oxide synthase, tumour necrosis factor-alpha, caspase-3, angiotensin II and endothelin-1 with a concurrent increase in renal levels of reduced glutathione and endothelial nitric oxide synthase compared to untreated rats. Histopathological examination confirmed the nephroprotective effect of nebivolol. Pre-treatment with Nω-nitro-L-arginine methyl ester, the non-specific nitric oxide synthase inhibitor, partially altered the protection afforded by nebivolol. In conclusion, nebivolol protects rats against cisplatin-induced nephrotoxicity that is most likely through its antioxidant, anti-inflammatory and antiapoptotic effects as well as by abrogation of the augmented angiotensin II and endothelin-1 levels.
- Subjects
NEBIVOLOL hydrochloride; CISPLATIN; NEPHROTOXICOLOGY; ADRENERGIC beta blockers; HISTOPATHOLOGY
- Publication
Basic & Clinical Pharmacology & Toxicology, 2016, Vol 118, Issue 6, p449
- ISSN
1742-7835
- Publication type
Article
- DOI
10.1111/bcpt.12538